ERS 2020 e-Poster : The effect of Simeox Airway Clearance Technology on resting hyperinflation in Cystic Fibrosis patients

We are pleased to have 3 e-Posters about Simeox that have been selected to be shown during #ERS2020. Yesterday, we introduced the first one “Physiological effects of Simeox Airway Clearance Device in healthy adults”.

Today, we are happy to present the second one “The effect of Simeox Airway Clearance Technology on resting hyperinflation in Cystic Fibrosis patients” that shows that Simeox seems to increase resting Inspiratory Capacity in CF patients suggesting a reduction of static lung hyperinflation.

Summary: Inspiratory Capacity (IC) is a suitable indicator of static lung hyperinflation and trapped air in Cystic Fibrosis (CF). A prospective multicenter study aimed to assess the effects of Simeox technology on resting IC in 21 clinically stable CF patients during one bronchial drainage session. After the device session, change in mean IC was significantly increased by 4±5% pred. (p<0.005). 11 responder patients (52%) had an increase of IC% pred ≥ 5% (9±4%, p<0.005).  These data suggest a direct effect of Simeox on static lung hyperinflation in some CF patients.

You’ll find the entire version of the e-Poster here